A Tumor Multicomponent Targeting Chemoimmune Drug Delivery System for Reprograming the Tumor Microenvironment and Personalized Cancer Therapy

Overview

Journal Drug Discov Today

Specialty Pharmacology

Date 2018 Mar 20

PMID 29551455

Citations 8

Authors

Samaresh Sau

Katyayani Tatiparti

Hashem O Alsaab

Sushil K Kashaw

Arun K Iyer

Affiliations

Soon will be listed here.

Abstract

Nanoparticle library engineered with tunable size, shape, and geometry will provide a better idea of targeting multicomponent of tumor microenvironment consisting of epithelial cells, tumor hypoxia, tumor immune cells and angiogenic blood vessels.

Citing Articles

Radiomics characterization of tissues in an animal brain tumor model imaged using dynamic contrast enhanced (DCE) MRI.

Bagher-Ebadian H, Brown S, Ghassemi M, Nagaraja T, Movsas B, Ewing J Sci Rep. 2023; 13(1):10693.

PMID: 37394559 PMC: 10315398. DOI: 10.1038/s41598-023-37723-8.

Advanced Optical Imaging-Guided Nanotheranostics towards Personalized Cancer Drug Delivery.

Murar M, Albertazzi L, Pujals S Nanomaterials (Basel). 2022; 12(3).

PMID: 35159744 PMC: 8838478. DOI: 10.3390/nano12030399.

ADAM17 Mediates Hypoxia-Induced Keratinocyte Migration via the p38/MAPK Pathway.

Zhu G, Liu J, Wang Y, Jia N, Wang W, Zhang J Biomed Res Int. 2021; 2021:8328216.

PMID: 34746310 PMC: 8568513. DOI: 10.1155/2021/8328216.

Progress in Clinical Trials of Photodynamic Therapy for Solid Tumors and the Role of Nanomedicine.

Alsaab H, Alghamdi M, Alotaibi A, Alzhrani R, Alwuthaynani F, Althobaiti Y Cancers (Basel). 2020; 12(10).

PMID: 33003374 PMC: 7601252. DOI: 10.3390/cancers12102793.

Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems.

Alzhrani R, Alsaab H, Petrovici A, Bhise K, Vanamala K, Sau S Drug Discov Today. 2019; 25(4):718-730.

PMID: 31758914 PMC: 7200292. DOI: 10.1016/j.drudis.2019.11.006.

References

Schiff D, Kesari S, de Groot J, Mikkelsen T, Drappatz J, Coyle T . Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma. Invest New Drugs. 2014; 33(1):247-53. DOI: 10.1007/s10637-014-0186-2. View

Moses J, Moorhouse A . The growing applications of click chemistry. Chem Soc Rev. 2007; 36(8):1249-62. DOI: 10.1039/b613014n. View

Dehaini D, Fang R, Luk B, Pang Z, Hu C, Kroll A . Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery. Nanoscale. 2016; 8(30):14411-9. PMC: 4977227. DOI: 10.1039/c6nr04091h. View

Karkada M, Berinstein N, Mansour M . Therapeutic vaccines and cancer: focus on DPX-0907. Biologics. 2014; 8:27-38. PMC: 3930480. DOI: 10.2147/BTT.S55196. View

Knudsen K, Northeved H, Kumar P, Permin A, Gjetting T, Andresen T . In vivo toxicity of cationic micelles and liposomes. Nanomedicine. 2014; 11(2):467-77. DOI: 10.1016/j.nano.2014.08.004. View

Almansour A, Arumugam N, Kumar R, Mahalingam S, Sau S, Bianchini G . Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues. Eur J Med Chem. 2017; 138:932-941. DOI: 10.1016/j.ejmech.2017.07.027. View

Kesharwani P, Xie L, Banerjee S, Mao G, Padhye S, Sarkar F . Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Colloids Surf B Biointerfaces. 2015; 136:413-23. DOI: 10.1016/j.colsurfb.2015.09.043. View

Gawde K, Kesharwani P, Sau S, Sarkar F, Padhye S, Kashaw S . Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue. J Colloid Interface Sci. 2017; 496:290-299. DOI: 10.1016/j.jcis.2017.01.092. View

Abeylath S, Ganta S, Iyer A, Amiji M . Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery. Acc Chem Res. 2011; 44(10):1009-17. DOI: 10.1021/ar2000106. View

10.

Kolb H, Finn M, Sharpless K . Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angew Chem Int Ed Engl. 2001; 40(11):2004-2021. DOI: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5. View

11.

Tang D, Wang D, Yuan Z, Xue X, Zhang Y, An Y . Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int J Cancer. 2012; 132(5):993-1003. DOI: 10.1002/ijc.27715. View

12.

Wickens J, Alsaab H, Kesharwani P, Bhise K, Amin M, Kumar Tekade R . Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov Today. 2016; 22(4):665-680. PMC: 5413407. DOI: 10.1016/j.drudis.2016.12.009. View

13.

Susa M, Iyer A, Ryu K, Choy E, Hornicek F, Mankin H . Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma. PLoS One. 2010; 5(5):e10764. PMC: 2875382. DOI: 10.1371/journal.pone.0010764. View

14.

Jain S, Doshi A, Iyer A, Amiji M . Multifunctional nanoparticles for targeting cancer and inflammatory diseases. J Drug Target. 2013; 21(10):888-903. DOI: 10.3109/1061186X.2013.832769. View

15.

Ting D, Lipson D, Paul S, Brannigan B, Akhavanfard S, Coffman E . Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science. 2011; 331(6017):593-6. PMC: 3701432. DOI: 10.1126/science.1200801. View

16.

Getts D, Shea L, Miller S, King N . Harnessing Nanoparticles for Immune Modulation: (Trends in Immunology 36, 419-427; July 2016). Trends Immunol. 2016; 37(10):715. PMC: 8445247. DOI: 10.1016/j.it.2016.08.003. View

17.

Zorde Khvalevsky E, Gabai R, Rachmut I, Horwitz E, Brunschwig Z, Orbach A . Mutant KRAS is a druggable target for pancreatic cancer. Proc Natl Acad Sci U S A. 2013; 110(51):20723-8. PMC: 3870687. DOI: 10.1073/pnas.1314307110. View

18.

Schroeder A, Heller D, Winslow M, Dahlman J, Pratt G, Langer R . Treating metastatic cancer with nanotechnology. Nat Rev Cancer. 2011; 12(1):39-50. DOI: 10.1038/nrc3180. View

19.

Amjad M, Amin M, Katas H, Butt A, Kesharwani P, Iyer A . In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas. Mol Pharm. 2015; 12(12):4247-58. DOI: 10.1021/acs.molpharmaceut.5b00827. View

20.

Li M, Kim H, Tian L, Yu M, Jon S, Moon W . Comparison of Two Ultrasmall Superparamagnetic Iron Oxides on Cytotoxicity and MR Imaging of Tumors. Theranostics. 2012; 2(1):76-85. PMC: 3263518. DOI: 10.7150/thno.3462. View